CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-03-12 | JACOBS CINDY EVP, CMO | Grant or award · Restricted Stock Unit (RSU) | +10,000 | 10,000 | ||
| 2013-03-12 | JACOBS CINDY EVP, CMO | Grant or award · Restricted Stock Unit (RSU) | +20,000 | 20,000 | ||
| 2013-03-12 | Cormack Scott Daniel President and CEO | Option exercise | +4,688 | 58,922 | ||
| 2013-03-12 | Cormack Scott Daniel President and CEO | Shares withheld for taxes | −2,134 | 56,788 | ||
| 2013-03-12 | Cormack Scott Daniel President and CEO | Option exercise · Restricted Stock Unit (RSU) | −4,688 | 14,062 | ||
| 2013-03-12 | Cormack Scott Daniel President and CEO | Grant or award · Stock Option (right to buy) | +37,500 | 37,500 | ||
| 2013-03-12 | Cormack Scott Daniel President and CEO | Grant or award · Restricted Stock Unit (RSU) | +18,750 | 18,750 | ||
| 2013-03-12 | Cormack Scott Daniel President and CEO | Grant or award · Restricted Stock Unit (RSU) | +30,000 | 30,000 | ||
| 2012-10-18 | Clendeninn Neil James Director | Option exercise | +513 | $4.11 | $2K | 7,562 |
| 2012-10-18 | Clendeninn Neil James Director | Option exercise · Stock Option | −513 | 0 | ||
| 2012-08-15 | GOLDSTEIN JACK Director | Purchase | +1,000 | $14.38 | $14K | 1,000 |
| 2012-08-07 | Cormack Scott Daniel President and CEO | Option exercise | +7,000 | $4.11 | $29K | 54,234 |
| 2012-08-07 | Cormack Scott Daniel President and CEO | Option exercise · Stock Option | −7,000 | 0 | ||
| 2012-08-03 | Clendeninn Neil James Director | Option exercise | +3,702 | $4.11 | $15K | 7,049 |
| 2012-08-03 | Clendeninn Neil James Director | Option exercise · Stock Option | −3,702 | 0 | ||
| 2012-07-30 | Cormack Scott Daniel President and CEO | Option exercise | +34,167 | $4.11 | $140K | 47,234 |
| 2012-07-30 | Cormack Scott Daniel President and CEO | Option exercise · Stock Option | −34,167 | 7,000 | ||
| 2012-06-01 | MATTINGLY MARTIN A Director | Purchase | +1,000 | $12.46 | $12K | 1,000 |
| 2012-05-31 | Smith David V Director | Grant or award · Stock Option (right to buy) | +4,000 | 4,000 | ||
| 2012-05-31 | Smith David V Director | Grant or award · Restricted Stock Unit | +2,000 | 2,000 |
Page 32 of 36 · 715 trades